Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus

DNA vaccines offer promising strategies for immunization against infections. However, their clinical use requires improvements in immunogenicity. We explored the efficacy of Toll-like receptor (TLR) ligands (TLR-Ls) on augmenting the immunogenicity of a DNA prime–modified vaccinia virus Ankara (MVA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwissa, Marcin, Amara, Rama R., Robinson, Harriet L., Moss, Bernard, Alkan, Sefik, Jabbar, Abdul, Villinger, Francois, Pulendran, Bali
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2007
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118478/
https://www.ncbi.nlm.nih.gov/pubmed/17954572
http://dx.doi.org/10.1084/jem.20071211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118478/
https://www.ncbi.nlm.nih.gov/pubmed/17954572
http://dx.doi.org/10.1084/jem.20071211

Ejemplares similares